|
Market Closed -
Nasdaq
21:00:00 20/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 62.92 USD | +2.26% |
|
+5.01% | -17.17% |
| 10-15 | UBS Adjusts Price Target on PTC Therapeutics to $90 From $80, Maintains Buy Rating | MT |
| 10-08 | RBC Cuts Price Target on PTC Therapeutics to $75 From $85, Keeps Sector Perform Rating | MT |
| Market Cap | 5.25B 4.67B 4.33B 3.93B 7.38B 497B 7.5B 51.98B 20.42B 260B 19.7B 19.29B 831B | P/E 2026 * |
44.8x | P/E 2027 * | 26.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.38B 3.01B 2.79B 2.53B 4.75B 320B 4.83B 33.46B 13.14B 168B 12.68B 12.42B 535B | EV / Sales 2026 * |
2.69x | EV / Sales 2027 * | 2.26x |
| Free-Float |
92.69% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTCT | Delayed | |
CBOE
| PTCT | Real-time | |
|
Tradegate
| BH3 | Real-time | |
|
Deutsche Boerse AG
| BH3 | Delayed | |
|
Börse Stuttgart
| BH3 | Delayed | |
|
Boerse Muenchen
| BH3 | Real-time | |
|
Xetra
| BH3 | Delayed |
Last Transcript: PTC Therapeutics, Inc.
| 1 day | +2.26% | ||
| 1 week | +5.01% | ||
| Current month | -2.87% | ||
| 1 month | -3.75% | ||
| 3 months | -19.34% | ||
| 6 months | -13.00% | ||
| Current year | -17.17% |
| 1 week | 58.98 |  | 63.24 |
| 1 month | 58.8 | | 66.58 |
| Current year | 58.8 | | 90.87 |
| 1 year | 58.8 | | 90.87 |
| 3 years | 17.53 | | 90.87 |
| 5 years | 17.53 | | 90.87 |
| 10 years | 4.03 | | 90.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 54 | 21/03/2023 |
Pierre Gravier
DFI | Director of Finance/CFO | 41 | 12/07/2023 |
| Chief Tech/Sci/R&D Officer | - | 30/09/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 31/10/2004 | |
Allan Jacobson
CHM | Chairman | 80 | 30/03/1998 |
David Southwell
BRD | Director/Board Member | 65 | 30/11/2005 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/10/26 | Other | Chairman | 0 | 0% | ||
| 14/10/26 | Section Six Partners
| Sell | Company | -2,500 | 0.0030% | |
| 09/10/26 | Exercice | General Counsel | 576 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.26% | +5.01% | -7.96% | +171.09% | 5.25B | |
| +3.49% | +10.04% | +58.68% | +119.56% | 1,144B | |
| +2.19% | +4.32% | +33.88% | +69.52% | 625B | |
| +2.26% | +5.37% | +24.57% | +97.69% | 511B | |
| -0.01% | +5.37% | +39.17% | +64.51% | 377B | |
| +3.25% | +4.45% | +71.80% | +44.44% | 366B | |
| +0.08% | +3.33% | +21.21% | +49.99% | 291B | |
| -0.03% | +2.72% | +1.28% | +25.09% | 262B | |
| +3.29% | +6.32% | +44.71% | +57.43% | 237B | |
| +2.25% | +5.81% | +27.13% | +101.17% | 194B | |
| Average | +0.41% | +6.18% | +31.45% | +80.05% | 401.32B | |
| Weighted average by Cap. | -0.06% | +6.91% | +40.93% | +81.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.26B 1.12B 1.04B 940M 1.77B 119B 1.8B 12.45B 4.89B 62.33B 4.72B 4.62B 199B | 1.38B 1.23B 1.14B 1.03B 1.93B 130B 1.97B 13.63B 5.36B 68.27B 5.17B 5.06B 218B |
| Net income | 130M 115M 107M 96.93M 182M 12.28B 185M 1.28B 504M 6.43B 486M 476M 20.51B | 200M 178M 165M 150M 281M 18.96B 286M 1.98B 778M 9.92B 751M 735M 31.65B |
| Net Debt | -1.87B -1.67B -1.54B -1.4B -2.63B -177B -2.67B -18.52B -7.28B -92.76B -7.02B -6.87B -296B | -2.15B -1.91B -1.77B -1.6B -3.01B -203B -3.06B -21.24B -8.34B -106B -8.05B -7.88B -339B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/10/26 | US$62.92 | +2.26% | 965,774 |
| 19/10/26 | US$61.53 | +3.87% | 943,991 |
| 16/10/26 | US$59.24 | -2.87% | 788,980 |
| 15/10/26 | US$60.99 | +2.21% | 1,051,889 |
| 14/10/26 | US$59.67 | -0.42% | 1,519,817 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTCT Stock
Select your edition
All financial news and data tailored to specific country editions
